JP Morgan Chase
DSCI

JP Morgan Chase’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

JP Morgan Chase’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-500
Closed -$2K – 5341
2016
Q3 		$2K Buy
+500
New +$2.33K ﹤0.01% 4465
2016
Q2 		– Sell
-1,000
Closed -$3K – 5252
2016
Q1 		$3K Buy
+1,000
New +$3.35K ﹤0.01% 4498
2015
Q2 		– Sell
-224,716
Closed -$1.9M – 4387
2015
Q1 		$1.9M Sell
224,716
-549,641
-71% -$4.68M ﹤0.01% 2902
2014
Q4 		$7.21M Sell
774,357
-271,230
-26% -$2.36M ﹤0.01% 2166
2014
Q3 		$8.71M Hold
1,045,587
– – ﹤0.01% 2019
2014
Q2 		$12.1M Sell
1,045,587
-18
-0% -$185 ﹤0.01% 1648
2014
Q1 		$13.3M Buy
1,045,605
+1,029,623
+6,442% +$13.3M ﹤0.01% 1567
2013
Q4 		$173K Buy
+15,982
New +$186K ﹤0.01% 3836
2013
Q3 		– Sell
-10,332
Closed -$138K – 4612
2013
Q2 		$138K Buy
+10,332
New +$133K ﹤0.01% 4082

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

JP Morgan Chase's DSCI Position: Q4 2016 in Review

JP Morgan Chase sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2016, closing a stake of 500 shares — an estimated $2K sold.

JP Morgan Chase first reported a position in DSCI in Q2 2013 and held it in 9 quarters. The position peaked at $13.3M in Q1 2014. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

  • JP Morgan Chase reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2016 after selling out during the quarter.
  • JP Morgan Chase sold 500 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $2K.
  • JP Morgan Chase first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 9 quarters.
  • JP Morgan Chase's Derma Sciences, Inc. Common Stock (DE) position peaked at $13.3M in Q1 2014.
  • 52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on JP Morgan Chase's 13F filing for Q4 2016, filed 6 Feb 2017.